New investment in Eupry ApS

Eupry Closes Series A Round of Over DKK 170 Million with Chr. Augustinus Fabrikker as a New Shareholder

The Danish-founded technology company Eupry, with its combined hardware and software solution, unites three compliance industries into one. The company has developed and refined a solution allowing pharmaceutical, biotech, and logistics companies to digitize processes that have traditionally been manual, time-consuming, and risk-prone.

Global demand for digitized solutions has made Eupry a highly attractive player in the market, resulting in a Series A funding round of over DKK 170 million, with the foundation-owned investment company Chr. Augustinus Fabrikker as the primary investor.

The capital injection will be used to strengthen the company’s established position in the U.S. market and further develop its product offerings.

Entering a New League with Prominent Danish Growth Companies

Chr. Augustinus Fabrikker has focused on "scale investments" since 2019, targeting promising Danish companies that have demonstrated proof of business and need capital to scale. Eupry is the ninth scale investment by Chr. Augustinus Fabrikker, joining the ranks of other notable Danish growth companies such as Stiesdal, Veo Technologies, Zenegy, and Podimo.

"We have been following Eupry for a long time and are impressed by their innovative temperature monitoring and data management solutions, which are now set to anchor on a global scale. We see tremendous potential in Eupry and are pleased and proud to welcome them to Chr. Augustinus Fabrikker — and contribute to their further journey. With their groundbreaking products, ambitions, and a skilled and dedicated team, Eupry fits perfectly into our scale investment strategy, and we look forward to unlocking the potential together with Eupry, EIFO, Ugly Duckling Venture, and Sagitta," Claus Gregersen, CEO of Chr. Augustinus Fabrikker.

Eupry represents the 19th ownership in Chr. Augustinus Fabrikker’s portfolio, which also includes prominent, established companies such as Tivoli, Royal Unibrew, itm8, and Abacus Medicine.

A Long-Term and Ambitious Investor

Chr. Augustinus Fabrikker is renowned for its long-term investment strategy and respect for balancing daily management and ownership. Eupry CEO Christian Jacobsen comments that this approach was a decisive factor for the company.

EIFO Partner & Head of Life Science Mads Lacoppidan sees significant potential in Chr. Augustinus Fabrikker joining Eupry’s investor group.

"EIFO and Chr. Augustinus Fabrikker works together in several Danish growth companies. We know them as one of the Danish investors who are best at creating change within venture growth. They have an incredibly strong network and can significantly contribute to the scaling up of their portfolio companies. Therefore, we see it as a very positive development for Eupry that they are now entering the ownership circle."

A Recognized Group of Investors

In addition to the lead investor, Chr. Augustinus Fabrikker, the funding round was supported by Eupry’s existing investors, Ugly Duckling Ventures, EIFO (formerly the Danish Growth Fund), and Sagitta.

“We deeply value the continued support from our existing investors and their willingness to drive the process forward and facilitate the right introductions. They have been invaluable through the years, contributing actively to the board as well as daily operations,” says Christian Jacobsen.

Ugly Duckling Venture Co-Founder Andreas Green Rasmussen, Chairman of Eupry’s Board, shared his thoughts on the venture fund’s continued engagement in Eupry and the Series A round:

"After nearly two years as the company's Chairman of the Board, I could not be more proud of this preliminary highlight for Eupry. It has been a fantastic joint effort, and we look forward to creating the next big Danish life science-related success with a strong co-investor in Chr. Augustinus Fabrikker." Andreas Green Rasmussen, Ugly Duckling Ventures co-founder and chairman of the board at Eupry.